Controlled release remains one of the most important innovate areas in pharma, with revenues set to dramatically increase to 2020. Recent advances in drug delivery systems have created the perfect mix for opportunities in the field.
SMi is proud to present its 10th annual controlled release conference, held in central London on the 18 & 19 March 2013 the meeting will continue in a long tradition of critically acclaimed speakers who are pioneers in their field. This event offers you a unique opportunity to keep up to date with the latest in technologies and methods such as the diffusion of nanomaterials through biological and non-biological gels.
Controlled Release 2013 will aim to show you recent trends in drug delivery such as inorganic controlled release, such as silica materials in drug delivery. RNAi is an important field - our 2013 meeting can show the latest data on RNAi delivery by nanodiamonds and avoiding capture by reticulo endothelium systems.
Discover the very latest developments in this innovative and booming industry
New for 2013:
- Investigating structure-activity relationships of siRNA nanoparticles
- Challenges of pre-clinical gastro-retentive dosage form development
- Numerous case studies from big pharma laboratories – such as GSKs formulation
development programme
Meet, share knowledge and do business with key industry professionals, leading
academics and healthcare representatives
You should attend this event if you are a Director, Area head, Chief Executive, CSO, or Vice President within the pharmaceutical or healthcare industry with responsibilities in the following areas
- Nanomedicine
- Drug Delivery
- Drug Development
- Formulation
- Business Development
- Product Development
- Research & Development
- Global Alliances
- Technical Sciences / Design